EADO Certification in Medical Tumor Therapy

 

I. DEFINITION, SCOPE

Definition The advanced continuing medical education training in "Medical Tumour Therapy in Dermatooncology" is intended as an addition to the specialist dermatologist's competence, and covers the administration and monitoring of medical therapy of patients with malignant skin tumours, including supportive measures and  management of  complications and side-effects from therapy.

The professional competence in systemic therapy for skin cancers obtained after completing the required training period will be certified by the European Certificate for Medical Tumour Therapy in Dermatooncology awarded by EADO in collaboration with UEMS.

II. PREREQUISITES FOR CANDIDATES TO CERTIFICATION:

  • Certification of specialist in dermatology by the relevant national authority (Board Certification)
  • Completion of the Training
  • Attendance of at least one ESDO course
  • Examination by the EADO Board for Certification in Dermato-oncology

III. TRAINING REQUIRED [see detailed text below]


IV. EXAMINATION PROCEDURE AND APPLICATION [see links below]


V. TRAINING CENTERS [see information below]

 

 Committee for Certification in Medical Tumour Therapy in Dermato-Oncology

Ana-Maria Forsea, Petr Arenberger, Lidija Kandolf-Seculovic Josep Malvehy

 

Claus Garbe             Alexander Stratigos             Ketty Peris
President                   Vice President                      Secretary General

III. TRAINING REQUIREMENTS

Content of the training program:

The acquisition of knowledge, experience and skills in the selection, administration and monitoring of the anti-neoplastic therapies for skin cancers, including targeted,  immunomodulatory, and cytostatic therapy, the subsequent monitoring and follow-up of patients receiving these therapies, the management of complications and side-effects related to antineoplastic therapies, and the use of best supportive care in advanced cases.

Training duration:

12 months involved in direct patients care in the following conditions:

  • Under the supervision of a recognized trainer with competence in medical tumour therapy in Dermatooncology, or expert in the field.
  • In an EADO-Certified Training Centre for Dermato-Oncology (see under Training Centres) OR in a Department of Medical Oncology, Haematology-Oncology or equivalent accredited at national level to treat patients with skin cancers with systemic (or medical) therapy
  • The period of total 12 months can be completed continuously or in several separated time blocks, in different centres fulfilling the criteria above, within a period of 3 years

Knowledge to be acquired during training

Theoretical knowledge of:

  • The indications for therapy for advanced, non-operable or metastatic skin cancers, including targeted therapy, immunotherapy, chemotherapy, surgery and radiation therapy
  • The indication and role for adjuvant and neo-adjuvant therapy in melanoma and skin cancer patients
  • The complications and toxicity of each type of therapy and their management
  • The risk–benefit ratio for treatments
  • The use of molecular, Immunohistological, and imaging markers for monitoring the success of therapy/side effects.

All knowledge should be at the optimal level, according to the European guidelines of best practice valid at the date

Practical skills to be acquired during training:

  • Ability to actively contribute to multidisciplinary discussions establishing the diagnosis, stage and treatment plans
  • Ability to identify and manage conditions (stage, performance status, comorbidities, prior therapies, family history) that will influence therapeutic and care strategies
  • Ability to identify emergent/urgent conditions such as brain metastases, carcinomatous meningitis and bowel obstruction and to develop treatment approaches
  • Ability to discuss options for therapy by stage and to discuss with patients and their family the complications of targeted therapy, immunotherapy, radiation therapy and surgery as well as the role of investigational agents
  • Ability to rapidly identify specific toxicities related to oncologic therapies and to apply appropriate management guidelines
  • Ability to use molecular and immunohistochemical biomarkers in orienting  therapy strategies
  • Ability to address risk and benefits with the patient
  • Ability to evaluate treatment outcomes, toxicity and the management of these complications, including decision to change or end therapy
  • Ability to manage clinical trials, including a certificate for a GCP training

 IV. EXAMINATION PROCEDURE

Examinations for obtaining the European Certificate for Medical Tumour Therapy in Dermatooncology will take place at the end of the annual European School of Dermato-Oncology (ESDO) course in January each year.

The examination will test the knowledge and skills described above. It will consist of a written examination in the form of Multiple Choice Questions.

 The examination fee is 200 €.

Application for examination

Candidates will apply by sending to info@eado.org the following documents:

  • Application form, filled out and signed (download form here)
  • Copy of the Board Certificate in Dermatology
  • Logbook of training activities performed, signed and stamped by the supervisors of each training institution  (download form here)
  • Curriculum vitae.
  • Copy of the diploma of attendance of an ESDO course, or the proof of registration for the upcoming ESDO course during which the Examination will take place
  •  
    • Should include detailed information about training periods and fields of activity. Scientific projects and special training courses in the field of dermato-oncology should be described

Applications will be accepted until November 1st each year, for the Examination in January of the following year.

 The completed files will be verified for conformity by the EADO Certification Committee. The applicants will be notified regarding their eligibility for the Examination by November 30th. Eligible applicants will be invited to take the examination after settling the examination fee of 200 EUR.

 V. TRAINING CENTRES

The list of currently EADO accredited Training Centres for Dermato-Oncology

V.1. General criteria

The training centre should have (within the centre site OR available through network cooperation):

  • Modern inpatient, ambulatory care and laboratory facilities necessary for the overall educational program for the different skin cancers
  • Adequate pathology services,
  • Modern diagnostic radiology services,
  • Resources for nuclear medicine imaging,
  • Blood banking, blood therapy facilities, facilities for clinical pharmacology and tumour immunology/biology.
  • A general surgical service and its support available, access to radiation therapy.
  • A set-up for regular multidisciplinary tumour conferences
  • Set up for clinical trials on Good Clinical Practice base 
  • A training supervisor with expertise in the field of tumour therapy in Dermatooncology 

V.2. EADO certification of “Training Centres for Medical Tumour Therapy in Dermatooncology”

The Centres of Dermato-Oncology which apply for the EADO Certification as Training Centres for Medical Tumour Therapy in Dermato-oncology should complete an application file and send it to the EADO Certification Committee at info@eado.org

Application form can be downloaded here.  

EADO will verify the compliance with the above criteria by means of filled application form by the centre and possibly visit of the site.

Visits from representatives (on-site inspection) may be necessary and will include evaluation of the facility, interview with the supervisor of the training program, teaching staff, and trainees. The program will have a mechanisms of re-accreditation (re-evaluation after 5 years for continuing professional development or if there is a change of the program director) 

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Ok Read more